Encyclopedia Britannica
Encyclopedia Britannica
SUBSCRIBE
SUBSCRIBE
SUBSCRIBE TO PREMIUM
  • Home
  • Biographies
  • Animals & Nature
  • History & Society
  • Science & Tech
  • Geography & Travel
  • Arts & Culture
  • ProCon
  • Money
  • Games & Quizzes
  • Videos
  • Today in History
  • Dictionary
  • New Articles
Biographies
  • Browse Biographies
Animals & Nature
  • Birds, Reptiles & Other Vertebrates
  • Environment
  • Fossils & Geologic Time
  • Insects & Other Invertebrates
  • Mammals
  • Plants
History & Society
  • History
  • Philosophy & Religion
  • Politics, Law & Government
  • Society & Social Issues
Science & Tech
  • Health & Medicine
  • Science
  • Technology
Geography & Travel
  • Geography & Travel
Arts & Culture
  • Entertainment & Pop Culture
  • Literature
  • Sports & Recreation
  • Visual Arts
  • Image Galleries
  • Podcasts
  • Summaries
  • Top Questions
  • Lists and Stories
  • Britannica Kids
Ask the Chatbot Games & Quizzes History & Society Science & Tech Biographies Animals & Nature Geography & Travel Arts & Culture ProCon Money Videos
ZMapp
References
Britannica AI Icon

ZMapp

medical treatment
Written by
The Information Architects of Encyclopaedia Britannica

The Information Architects maintain a master list of the topics included in the corpus of  Encyclopædia Britannica, and create and manage the relationships between them.

The Information Architects of Encyclopaedia Britannica

Learn about this topic in these articles:

  • Ebolavirus and Ebola virus disease
    Ebola
    / Treatment

    …antiviral drug remdesivir (RDV) and ZMapp, a mixture of three antibodies that bind to proteins on ebolaviruses. ZMapp was administered to infected individuals during the 2014–16 outbreak, though its effectiveness was unclear. In trials during the 2018–20 Ebola outbreak, both REGN-EB3 and mAb114 were found to be more effective at…

    Read More

    …antiviral drug remdesivir (RDV) and ZMapp, a mixture of three antibodies that bind to proteins on ebolaviruses. ZMapp was administered to infected individuals during the 2014–16 outbreak, though its effectiveness was unclear. In trials during the 2018–20 Ebola outbreak, both REGN-EB3 and mAb114 were found to be more effective at…

    Read More